loading
Schlusskurs vom Vortag:
$31.15
Offen:
$31.61
24-Stunden-Volumen:
215.22K
Relative Volume:
0.06
Marktkapitalisierung:
$4.90B
Einnahmen:
$264.79M
Nettoeinkommen (Verlust:
$-14.36M
KGV:
-116.64
EPS:
-0.28
Netto-Cashflow:
$67.82M
1W Leistung:
+4.08%
1M Leistung:
+31.73%
6M Leistung:
+93.39%
1J Leistung:
+160.57%
1-Tages-Spanne:
Value
$31.36
$32.46
1-Wochen-Bereich:
Value
$28.59
$32.25
52-Wochen-Spanne:
Value
$12.26
$36.50

Tg Therapeutics Inc Stock (TGTX) Company Profile

Name
Firmenname
Tg Therapeutics Inc
Name
Telefon
(212) 554-4484
Name
Adresse
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Name
Mitarbeiter
264
Name
Twitter
@TGTherapeutics
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
TGTX's Discussions on Twitter

Vergleichen Sie TGTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
TGTX 32.46 4.90B 264.79M -14.36M 67.82M -0.28
VRTX 447.95 115.74B 10.63B -479.80M -1.35B 13.33
REGN 741.90 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 590.56 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.60 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.56 24.49B 3.30B -501.07M 1.03B 11.54

Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-08-02 Hochstufung Goldman Sell → Neutral
2023-06-26 Fortgesetzt Jefferies Buy
2022-05-20 Eingeleitet BofA Securities Underperform
2022-02-23 Bestätigt B. Riley Securities Buy
2021-11-15 Herabstufung Goldman Neutral → Sell
2021-04-20 Eingeleitet Goldman Neutral
2021-04-19 Bestätigt H.C. Wainwright Buy
2020-09-01 Eingeleitet JP Morgan Overweight
2020-08-11 Bestätigt H.C. Wainwright Buy
2020-06-05 Eingeleitet Evercore ISI Outperform
2020-01-17 Bestätigt H.C. Wainwright Buy
2019-11-27 Fortgesetzt B. Riley FBR Buy
2019-02-06 Fortgesetzt Jefferies Buy
2018-09-25 Herabstufung Raymond James Strong Buy → Outperform
2018-03-09 Bestätigt B. Riley FBR, Inc. Buy
2017-12-01 Fortgesetzt B. Riley FBR, Inc. Buy
2017-11-14 Fortgesetzt H.C. Wainwright Buy
2017-04-25 Eingeleitet Jefferies Buy
2017-03-06 Bestätigt FBR & Co. Outperform
2016-10-06 Fortgesetzt Brean Capital Buy
2016-05-27 Eingeleitet SunTrust Buy
2015-12-01 Eingeleitet FBR Capital Outperform
2015-09-09 Eingeleitet Raymond James Strong Buy
2015-08-12 Fortgesetzt H.C. Wainwright Buy
2015-06-19 Bestätigt Brean Capital Buy
2014-12-11 Bestätigt ROTH Capital Buy
2014-12-10 Bestätigt ROTH Capital Buy
Alle ansehen

Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten

pulisher
06:02 AM

TG Therapeutics Ranked Number One Fastest-Growing Company - GlobeNewswire

06:02 AM
pulisher
06:00 AM

TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™ - Yahoo Finance

06:00 AM
pulisher
Nov 20, 2024

Oppenheimer & Co. Inc. Acquires New Shares in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

Nov 20, 2024
pulisher
Nov 18, 2024

State of New Jersey Common Pension Fund D Decreases Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

When (TGTX) Moves Investors should Listen - Stock Traders Daily

Nov 15, 2024
pulisher
Nov 15, 2024

Entropy Technologies LP Purchases Shares of 31,200 TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Principal Financial Group Inc. Raises Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by Amalgamated Bank - MarketBeat

Nov 15, 2024
pulisher
Nov 13, 2024

TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by Los Angeles Capital Management LLC - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

Insider Sale: Director Laurence Charney Sells 25,000 Shares of T - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Insider Sale: Director Sagar Lonial Sells 5,000 Shares of TG The - GuruFocus.com

Nov 12, 2024
pulisher
Nov 10, 2024

New York State Teachers Retirement System Invests $1 Million in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

Nov 10, 2024
pulisher
Nov 09, 2024

Don't Ignore The Insider Selling In TG Therapeutics - Simply Wall St

Nov 09, 2024
pulisher
Nov 08, 2024

TG Therapeutics stock hits 52-week high at $28.43 - Investing.com India

Nov 08, 2024
pulisher
Nov 08, 2024

TG Therapeutics stock hits 52-week high at $28.43 By Investing.com - Investing.com Canada

Nov 08, 2024
pulisher
Nov 08, 2024

FY2024 EPS Estimates for TG Therapeutics Raised by Analyst - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

TG Therapeutics (NASDAQ:TGTX) Sets New 1-Year HighWhat's Next? - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

FY2027 EPS Forecast for TG Therapeutics Decreased by Analyst - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Optimistic Investors Push TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Up 27% But Growth Is Lacking - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

TG Therapeutics, Inc. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

FY2024 EPS Estimates for TG Therapeutics Lowered by Analyst - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

HC Wainwright Boosts Earnings Estimates for TG Therapeutics - MarketBeat

Nov 06, 2024
pulisher
Nov 05, 2024

TG Therapeutics Inc (TGTX) Q3 2024 Earnings: Revenue Hits $83.3M, EPS at $0.02, Surpassing Estimates - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

HC Wainwright Increases TG Therapeutics (NASDAQ:TGTX) Price Target to $55.00 - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

TG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early 2025 Updates (NASDAQ:TGTX) - Seeking Alpha

Nov 05, 2024
pulisher
Nov 05, 2024

TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $22.00 at The Goldman Sachs Group - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

TG Therapeutics (NASDAQ:TGTX) Announces Earnings Results - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 05, 2024
pulisher
Nov 05, 2024

TG Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 05, 2024
pulisher
Nov 05, 2024

TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Rec - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

Nov 05, 2024
pulisher
Nov 04, 2024

Earnings call: TG Therapeutics reports robust growth for BRIUMVI - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

TG Therapeutics: Q3 Earnings Snapshot - Darien Times

Nov 04, 2024
pulisher
Nov 04, 2024

Earnings call: TG Therapeutics reports robust growth for BRIUMVI By Investing.com - Investing.com UK

Nov 04, 2024
pulisher
Nov 04, 2024

TG Therapeutics Posts Strong Q3 Briumvi Revenue, Here’s Why Shares Fell - Seeking Alpha

Nov 04, 2024
pulisher
Nov 04, 2024

TG Therapeutics (TGTX) Lags Q3 Earnings Estimates - MSN

Nov 04, 2024
pulisher
Nov 04, 2024

(TGTX) Trading Advice - Stock Traders Daily

Nov 04, 2024
pulisher
Nov 04, 2024

FUJIFILM Diosynth Biotechnologies To Manufacture TG Therapeutics' MS Drug - Contract Pharma

Nov 04, 2024
pulisher
Nov 04, 2024

TG Therapeutics (NASDAQ:TGTX) Shares Gap DownHere's What Happened - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Morning Brew: Nvidia Joins Dow, Fed Rate Cut Looms, and TG Thera - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

TG Therapeutics, Inc. (NASDAQ:TGTX) Stock Holdings Increased by Raymond James & Associates - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

TG Therapeutics Reports Third Quarter 2024 Financial - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

TG Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 04, 2024
pulisher
Nov 04, 2024

TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Bought by Raymond James & Associates - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

State of Alaska Department of Revenue Acquires Shares of 76,130 TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

Nov 03, 2024

Finanzdaten der Tg Therapeutics Inc-Aktie (TGTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):